Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bruhn Newtech is a global leader in the development of CBRN (Chemical, Biological, Radiological, and Nuclear) defense software and consultancy services. The company specializes in hazard prediction, warning, and reporting systems designed to protect military forces and civilian populations from toxic threats, including biological agents. Their flagship software, CBRN-Analysis, is a standard-setting tool used by NATO and various international defense organizations for real-time decision support and information management. By integrating sensor data with advanced modeling, Bruhn Newtech provides critical biosecurity solutions that enhance situational awareness during public health crises and hazardous material incidents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bruhn Newtech Group.